New treatments for acute myeloid leukaemia

Bookmark and Share
Published: 10 Dec 2017
Views: 1777
Dr Anna Halpern - Seattle Cancer Care Alliance, Seattle, USA

Dr Halpern speaks with ecancer at the 2017 ASH annual meeting about the final results from the phase 1/2 trial looking at G-CSF, cladribine, cytarabine, and dose-escalated mitoxantrone (GCLAM) in adults with relapsed/refractory acute myeloid leukaemia or high-grade myeloid neoplasms.